Brief: India's Neuland Laboratories Posts March-Qtr Consol Loss
May 22 (Reuters) - Neuland Laboratories Ltd NEUL.NS :
* MARCH-QUARTER CONSOL LOSS 93 MILLION RUPEES VERSUS PROFIT
OF
66.4 MILLION RUPEES YEAR AGO
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.92 BILLION
RUPEES
VERSUS 1.73 BILLION RUPEES YEAR AGO
* RE-APPOINTS DAVULURI SAHARSH RAO AS WHOLE-TIME DIRECTOR
DESIGNATED AS JOINT MD
Source text for Eikon: ID:nBSE6PW1BT
Further company coverage: NEUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees